Harriet Lewis, medicines optimization lead for UK trade group the Association of the British Pharmaceutical Industry (ABPI), looks at the impact of biosimilar c 17 August 2017
When facing an illness, one of the first things that patients and caregivers do is go online for information, writes Dawn Lacallade, chief social strategist and 15 August 2017
It isn’t often a sector unquestioningly excels in internal practices, but Kunle Malomo, acting chief executive of Great Place to Work UK, considers, in an Exper 11 August 2017
Yungjoon Kwon, Korean patent/trademark attorney and managing director at law firm Kwon & Kim, introduces general practice and case laws related to medical use c 8 August 2017
Foundation Medicine, a US company specializing in genomic analysis diagnostics in oncology, looks at how advances in genomics have changed how we treat cancer i 2 August 2017
The benefits of patient-centric clinical trials, the role packaging can play, and why it is worth incurring up-front costs and inconveniences to put the patient 26 July 2017
The pharmaceutical industry is one of the UK’s great success stories, writes Michael Jewell, healthcare partner at Cavendish Corporate Finance, in an Expert Vie 20 July 2017
In an Expert View piece, Ivan Blanarik.senior vice president and head of biosimilars at privately-owned German pharma Boehringer Ingelheim. 13 July 2017
The growing number of clinical trials and increasing complexity across the clinical lifecycle are putting pressure on life sciences organizations to improve stu 4 July 2017
Todd Greenwood.director of digital Strategy at digital health specialists Medullan.provides an expert view on the value of real-world evidence and patient suppo 26 June 2017
In an Expert View piece, Karl Rotthier, chief executive of sustainable antibiotics company DSM Sinochem Pharmaceuticals, looks at the growing risk posed to phar 22 June 2017
The dramatic availability of new data sources along with the opportunity to leverage existing data pools.is radically changing the way we think about clinical t 14 June 2017
Colorectal cancer (CRC) exemplifies the steady progress we’ve made in cancer prevention and treatment.writes Dr Samuel Klempner.director of precision medicine a 25 May 2017
The cost of the clinical trial process today is upwards of $100 million.asks Ben van der Schaaf.principal at management consulting firm Arthur D.Little in an ex 17 May 2017
Biosimilar products.which have been circulating in Europe for about a decade.have emerged as a new category of drug within the USA’s pharmaceutical market – a t 10 May 2017
In a hard-hitting expert view piece, Dr Oded Ben-Joseph and Dr Shawn Manning, from investment bank Outcome Capital, advise on how life science companies can ach 3 May 2017
In an expert view piece, Dr Sinead Ni Mhurchadha of Atlantis Healthcare, a provider of personalized patient support programs, discusses the burden of chronic il 26 April 2017
In this week's Expert View.Gijs Hubben considers the role of value communication in facilitating market access for new pharmaceuticals.distilling his experience 17 April 2017
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.